Angiotensin II Receptor Antagonists

This publication has 62 references indexed in Scilit:

• A Risk-Benefit Assessment of Losartan Potassium in the Treatment of Hypertension
  Drug Safety, 1997
• Losartan Potassium
  Drugs, 1996
• Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension
  Hypertension, 1995
• A Randomized, Placebo-Controlled, Double-Blind, Parallel Study of Various Doses of Losartan Potassium Compared With Enalapril Maleate in Patients With Essential Hypertension
  Hypertension, 1995
• Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipne ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension
  The American Journal of Cardiology, 1995
• Biochemical Effects of Losartan, a Nonpeptide Angiotensin II Receptor Antagonist, on the Renin-Angiotensin-Aldosterone System in Hypertensive Patients
  Hypertension, 1995
• Hemodynamic and Biochemical Effects of the AT ₁ Receptor Antagonist Irbesartan in Hypertension
  Hypertension, 1995
• Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?
  Kidney International, 1994
• Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects.
  Hypertension, 1993
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987